D. Balakrishna

发表

Biological Characterization of TAK-901, an Investigational, Novel, Multitargeted Aurora B Kinase Inhibitor

Biching Sang, P. Farrell, Lihong Shi, 2013, Molecular Cancer Therapeutics.

CX3CL1-Fc treatment prevents atherosclerosis in Ldlr KO mice

A. Fanjul, K. Ley, J. Olefsky, 2018, Molecular metabolism.

Chronic fractalkine administration improves glucose tolerance and pancreatic endocrine function

Jong Bae Seo, A. Fanjul, J. Olefsky, 2018, The Journal of clinical investigation.

A critical role for inducible nitric oxide synthase in host survival following coxsackievirus B4 infection.

N. Sarvetnick, D. Balakrishna, M. Horwitz, 2001, Virology.

ICAM-1 Deficiency Blocks Accelerated the Nonobese Diabetic ( NOD ) Mouse : A Mechanism for IL-10-Mediated Diabetes in and

D. Balakrishna, A. Cava, Nancy K. Nguyen, 2000 .

Using Target Engagement Biomarkers to Predict Clinical Efficacy of MetAP2 Inhibitors

A. Fanjul, C. Zopf, Christopher Mcbride, 2019, The Journal of Pharmacology and Experimental Therapeutics.

A Mechanism for IL-10-Mediated Diabetes in the Nonobese Diabetic (NOD) Mouse: ICAM-1 Deficiency Blocks Accelerated Diabetes1 2

N. Sarvetnick, A. La Cava, D. Balakrishna, 2000, The Journal of Immunology.

Islet-Specific Expression of IL-10 Promotes Diabetes in Nonobese Diabetic Mice Independent of Fas, Perforin, TNF Receptor-1, and TNF Receptor-2 Molecules1

N. Sarvetnick, T. Hanafusa, D. Balakrishna, 2000, The Journal of Immunology.

Receptor-1 , and TNF Receptor-2 Molecules Independent of Fas , Perforin , TNF Diabetes in Nonobese Diabetic Mice Islet-Specific Expression of IL-10 Promotes

N. Sarvetnick, T. Hanafusa, D. Balakrishna, 2000 .

Discovery of the Bruton's Tyrosine Kinase Inhibitor Clinical Candidate TAK-020 (S)-5-(1-((1-Acryloylpyrrolidin-3-yl)oxy)isoquinolin-3-yl)-2,4-dihydro-3H-1,2,4-triazol-3-one, by Fragment-Based Drug Design.

J. Lawson, D. Balakrishna, D. Dougan, 2021, Journal of medicinal chemistry.

Target cell defense prevents the development of diabetes after viral infection

N. Sarvetnick, A. Yoshimura, D. Balakrishna, 2002, Nature Immunology.

MET Tyrosine Kinase Inhibition Enhances the Antitumor Efficacy of an HGF Antibody

J. Lawson, P. Vincent, K. Okada, 2017, Molecular Cancer Therapeutics.

Structure-based optimization of 1H-imidazole-2-carboxamides as Axl kinase inhibitors utilizing a Mer mutant surrogate.

J. Lawson, Walter Keung, J. Kahana, 2017, Bioorganic & medicinal chemistry letters.